Micro Ribonucleic Acid (miRNA) Expression and Inflammatory Factors in Patients With Parkinson's and Periodontal Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

February 1, 2026

Conditions
Periodontal Diseases Inflammation
Interventions
OTHER

Saliva and Serum

Saliva were collected to analyze the selected markers as unstimulated samples during the early hours of the day. The saliva was centrifuged and then transferred into Eppendorf tubes. Venous puncture was performed after saliva collection and 10 mL of blood samples were collected by qualified staff from each participant.Saliva and serum were then stored at -80 °C until analysis.

OTHER

Saliva and Serum

ELISA method will be used to measure TNF-α values in collected saliva and serum samples.RT-qPCR based miRNA gene expression analyses will be performed with 2-step qRT-PCR Kits (Thermofisher Scientific, MA, USA).

Trial Locations (1)

Unknown

Istanbul Medipol University, Istanbul

All Listed Sponsors
lead

Medipol University

OTHER

NCT07099378 - Micro Ribonucleic Acid (miRNA) Expression and Inflammatory Factors in Patients With Parkinson's and Periodontal Disease | Biotech Hunter | Biotech Hunter